Searched for
ORAL CONTRACEPTIVE TABLETS
Lupin gets USFDA nod for generic oral contraceptive pillLupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drosp...- Lupin gets USFDA approval for generic contraceptive drugThe company has received final approval from the USFDA to market its product which is a generic version of Bayer HealthCare Pharmaceutical ...
- Lupin gets USFDA nod for generic contraceptive tabletsThe company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Ba...
- Lupin initiates recall of tablet Mibelas 24 Fe from US marketAccording to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'clas...
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin today said it has received US health regulator's final approval to market Blisovi oral contraceptive tablets in different strengths i...
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- Lupin gains on FDA approval for oral contraceptiveShares of Lupin gained momentum in weak market after it received US FDA approval for oral contraceptive tablets.
- Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
- Oral Contraceptives Booster to Lupin's US businessAs per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.
- Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...
- Lupin gets USFDA nod to market generic contraceptive tabletsDrug firm Lupin today said it has received final approval from the US health regulator to market its generic Levonorgestrel and Ethinyl Est...
- Lupin gets USFDA approval for oral contraceptive tablets KurveloDrug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
- Glenmark recalls select lot of oral contraceptive in USGlenmark Pharmaceuticals today said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgesti...
- Glenmark Pharmaceuticals gets USFDA approval for oral contraceptivesGlenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic two oral contraceptives tab...
- Lupin eyes $150 mn from oral contraceptives in US by FY14Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Lupin gains on USFDA nod; Goldman recommends 'Buy'Shares of drugmaker Lupin rose nearly 2 percent after it received the US regulatory approval on Tuesday to launch oral contraceptive
- Lupin gets FDA approval for oral contraceptiveLPI has been granted final approval by the US FDA for its ANDA to market a generic version of Watson's NOR-QD® tablets.
Load More- Lupin initiates recall of tablet Mibelas 24 Fe from US market
